Related Experiment Video
Updated: Dec 7, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Important Tools for Use by Pediatric Endocrinologists in the Assessment of Short Stature
José I. Labarta1, Michael B. Ranke2, Mohamad Maghnie3,4
1University of Zaragoza, Children’s Hospital Miguel Servet, Instituto de Investigación Sanitaria de Aragón, Unit of Endocrinology, Zaragoza, Spain
Insights
Novel digital techniques are enhancing pediatric growth failure assessment. These advancements improve short stature referrals, diagnosis coding, imaging safety, bone age assessment, and growth hormone treatment predictions, optimizing patient care.
Area of Science:
- Pediatric Endocrinology
- Digital Health Technologies
- Growth Disorders
Background:
- Child growth failure assessment has advanced, but digital innovations offer further improvements.
- Pediatric endocrinologists utilize various tools for growth assessment and management.
- Digitalization is transforming the landscape of pediatric endocrine care.
Purpose of the Study:
- To review recent advancements in digital techniques for assessing and managing pediatric growth failure.
- To highlight how novel technologies are improving diagnostic accuracy and treatment prediction.
- To discuss the integration of digital tools into pediatric endocrinology practice.
Main Methods:
- Expert panel discussions at the 360° European Meeting on Growth and Endocrine Disorders.
- Review of novel digital tools including electronic monitoring, algorithms, and computer programs.
- Analysis of innovations in cranial imaging, bone age assessment, and growth hormone (GH) treatment prediction models.
Main Results:
- Electronic monitoring and algorithms enhance short stature referrals.
- Computer programs improve diagnostic coding for healthcare systems.
- Safer, more sensitive cranial imaging techniques are available.
- Deep learning improves objectivity in bone age and health assessment.
- Artificial intelligence enhances prediction of growth hormone therapy response.
- Standardized insulin-like growth factor-1 (IGF-1) interpretation and computer-learning models identify key predictors of GH therapy response.
Conclusions:
- Digital technologies offer significant potential to improve pediatric growth failure management.
- These advancements aim to enhance clinical decision-making, standardize assessments, and support patient-centered care.
- Physicians must stay informed about new digital developments while prioritizing clinical judgment.
Abstract:
Assessment and management of children with growth failure has improved greatly over recent years. However, there remains a strong potential for further improvements by using novel digital techniques. A panel of experts discussed developments in digitalization of a number of important tools used by pediatric endocrinologists at the third 360° European Meeting on Growth and Endocrine Disorders, funded by Merck KGaA, Germany, and this review is based on those discussions. It was reported that electronic monitoring and new algorithms have been devised that are providing more sensitive referral for short stature. In addition, computer programs have improved ways in which diagnoses are coded for use by various groups including healthcare providers and government health systems. Innovative cranial imaging techniques have been devised that are considered safer than using gadolinium contrast agents and are also more sensitive and accurate. Deep-learning neural networks are changing the way that bone age and bone health are assessed, which are more objective than standard methodologies. Models for prediction of growth response to growth hormone (GH) treatment are being improved by applying novel artificial intelligence methods that can identify non-linear and linear factors that relate to response, providing more accurate predictions. Determination and interpretation of insulin-like growth factor-1 (IGF-1) levels are becoming more standardized and consistent, for evaluation across different patient groups, and computer-learning models indicate that baseline IGF-1 standard deviation score is among the most important indicators of GH therapy response. While physicians involved in child growth and treatment of disorders resulting in growth failure need to be aware of, and keep abreast of, these latest developments, treatment decisions and management should continue to be based on clinical decisions. New digital technologies and advancements in the field should be aimed at improving clinical decisions, making greater standardization of assessment and facilitating patient-centered approaches.
Related Concept Videos
Nature and Nurture
Signs of Puberty
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...

